Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Paine

Showing results (81-90 of 175) with videos related to

Pageof 18
Sort By:
Natural Product Reports|January 26, 2019
Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approachJoshua J Kellogg, Mary F Paine, Jeannine S McCune, et al.
Journal of Addiction Medicine|February 15, 2022
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/NaloxoneHazel D Brogdon, Mackenzie M McPhee, Mary F Paine, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 28, 2020
Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric EffectsMatthew G McDonald, Dan-Dan Tian, Kenneth E Thummel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2014
Identification of diet-derived constituents as potent inhibitors of intestinal glucuronidationBrandon T Gufford, Gang Chen, Philip Lazarus, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2015
Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug InteractionBrandon T Gufford, Gang Chen, Ana G Vergara, et al.
Planta Medica|August 19, 2010
Isolation and identification of intestinal CYP3A inhibitors from cranberry (Vaccinium macrocarpon) using human intestinal microsomesEunkyung Kim, Arlene Sy-Cordero, Tyler N Graf, et al.
Regulatory Toxicology and Pharmacology : RTP|January 19, 2016
Assessing Natural Product-Drug Interactions: An End-to-End Safety FrameworkAmy L Roe, Mary F Paine, Bill J Gurley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 10, 2006
The human intestinal cytochrome P450 "pie"Mary F Paine, Heather L Hart, Shana S Ludington, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2004
Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?Mary F Paine, Shana S Ludington, Mei-Ling Chen, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Quantitative contributions of hepatic and renal organic cation transporters to the clinical pharmacokinetic cimetidine-metformin interactionAnoud Sameer Ailabouni, Dilip Kumar Singh, Aarzoo Thakur, et al.
Pageof 18

Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
Natural Product Reports|January 26, 2019
Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approachJoshua J Kellogg, Mary F Paine, Jeannine S McCune, et al.
Journal of Addiction Medicine|February 15, 2022
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/NaloxoneHazel D Brogdon, Mackenzie M McPhee, Mary F Paine, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 28, 2020
Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric EffectsMatthew G McDonald, Dan-Dan Tian, Kenneth E Thummel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2014
Identification of diet-derived constituents as potent inhibitors of intestinal glucuronidationBrandon T Gufford, Gang Chen, Philip Lazarus, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2015
Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug InteractionBrandon T Gufford, Gang Chen, Ana G Vergara, et al.
Planta Medica|August 19, 2010
Isolation and identification of intestinal CYP3A inhibitors from cranberry (Vaccinium macrocarpon) using human intestinal microsomesEunkyung Kim, Arlene Sy-Cordero, Tyler N Graf, et al.
Regulatory Toxicology and Pharmacology : RTP|January 19, 2016
Assessing Natural Product-Drug Interactions: An End-to-End Safety FrameworkAmy L Roe, Mary F Paine, Bill J Gurley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 10, 2006
The human intestinal cytochrome P450 "pie"Mary F Paine, Heather L Hart, Shana S Ludington, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2004
Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?Mary F Paine, Shana S Ludington, Mei-Ling Chen, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Quantitative contributions of hepatic and renal organic cation transporters to the clinical pharmacokinetic cimetidine-metformin interactionAnoud Sameer Ailabouni, Dilip Kumar Singh, Aarzoo Thakur, et al.
Pageof 18